NDC 0228-2348

Propylthiouracil

Propylthiouracil

Propylthiouracil is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Propylthiouracil.

Product ID0228-2348_20e93a90-36d0-4007-86ec-2094411b381b
NDC0228-2348
Product TypeHuman Prescription Drug
Proprietary NamePropylthiouracil
Generic NamePropylthiouracil
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2006-01-15
Marketing CategoryANDA / ANDA
Application NumberANDA080172
Labeler NameActavis Pharma, Inc.
Substance NamePROPYLTHIOURACIL
Active Ingredient Strength50 mg/1
Pharm ClassesThyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0228-2348-10

100 TABLET in 1 BOTTLE (0228-2348-10)
Marketing Start Date2006-01-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0228-2348-10 [00228234810]

Propylthiouracil TABLET
Marketing CategoryANDA
Application NumberANDA080172
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2006-01-15

Drug Details

Active Ingredients

IngredientStrength
PROPYLTHIOURACIL50 mg/1

OpenFDA Data

SPL SET ID:a57c49ae-d659-49fa-84e3-cf6d1f9e6f97
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198175
  • Pharmacological Class

    • Thyroid Hormone Synthesis Inhibitor [EPC]
    • Thyroid Hormone Synthesis Inhibitors [MoA]

    NDC Crossover Matching brand name "Propylthiouracil" or generic name "Propylthiouracil"

    NDCBrand NameGeneric Name
    0143-1480PropylthiouracilPropylthiouracil
    0228-2348PropylthiouracilPropylthiouracil
    0615-7583propylthiouracilpropylthiouracil
    42254-010PropylthiouracilPropylthiouracil
    67253-651PropylthiouracilPropylthiouracil
    68084-964PropylthiouracilPropylthiouracil
    70752-171PROPYLTHIOURACILPROPYLTHIOURACIL

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.